Literature DB >> 15163163

Normative data for functional assessment of cancer therapy--general scale and its use for the interpretation of quality of life scores in cancer survivors.

Bernhard Holzner1, Georg Kemmler, David Cella, Christina De Paoli, Verena Meraner, Martin Kopp, Richard Greil, W Wolfgang Fleischhacker, Barbara Sperner-Unterweger.   

Abstract

The aims of this study were to derive population-based reference values for the Functional Assessment of Cancer Therapy Scale-General (FACT-G) and to investigate the impact of sociodemographic variables (e.g. age, sex, health status) on these quality of life (QOL) scores, and to compare the normative QOL scores with those of various groups of cancer survivors. A random sample of 2 000 members of the Austrian public were sent questionnaires containing the FACT-G and questions relating to demographic data and health status. A total of 968 questionnaires were returned giving an overall response rate of 50.6% (females 48.3%, age 49.3 +/- 16.8). Subjects with higher education reported higher QOL values; divorced and widowed persons had significantly lower QOL scores. Higher age was also associated with lower QOL scores. After bone marrow transplantation, patients generally showed lower QOL scores than the age- and sex-matched population-based sample, whilst in breast cancer survivors there was reduced QOL regarding social well-being. Survivors of Hodgkin's disease were found to have higher functional and social well-being scores than those of the general population sample. Sociodemographic variables should always be taken into consideration when interpreting QOL scores. Furthermore, unless patient data are compared with normative values, phenomena such as adaptation and response shift might be missed or misinterpreted.

Entities:  

Mesh:

Year:  2004        PMID: 15163163     DOI: 10.1080/02841860310023453

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  33 in total

1.  Effects of global meaning and illness-specific meaning on health outcomes among breast cancer patients.

Authors:  Allen C Sherman; Stephanie Simonton; Umaira Latif; Lew Bracy
Journal:  J Behav Med       Date:  2010-05-26

2.  Age and gender differences in symptom intensity and symptom clusters among patients with metastatic cancer.

Authors:  Winson Y Cheung; Lisa W Le; Lucia Gagliese; Camilla Zimmermann
Journal:  Support Care Cancer       Date:  2010-03-24       Impact factor: 3.603

3.  Health-related quality of life 18 months after breast cancer: comparison with the general population of Queensland, Australia.

Authors:  Tracey DiSipio; Sandi Hayes; Beth Newman; Monika Janda
Journal:  Support Care Cancer       Date:  2008-01-16       Impact factor: 3.603

4.  A comparison of quality-of-life domains and clinical factors in ovarian cancer patients: a Gynecologic Oncology Group study.

Authors:  Vivian E von Gruenigen; Helen Q Huang; Karen M Gil; Heidi E Gibbons; Bradley J Monk; Peter G Rose; Deborah K Armstrong; David Cella; Lari Wenzel
Journal:  J Pain Symptom Manage       Date:  2010-05       Impact factor: 3.612

Review 5.  Reliability across studies from the functional assessment of cancer therapy-general (FACT-G) and its subscales: a reliability generalization.

Authors:  David Victorson; Joshua Barocas; Juliette Song; David Cella
Journal:  Qual Life Res       Date:  2008-10-08       Impact factor: 4.147

6.  Determinants of quality of life in patients with advanced cancer.

Authors:  Camilla Zimmermann; Debika Burman; Nadia Swami; Monika K Krzyzanowska; Natasha Leighl; Malcolm Moore; Gary Rodin; Ian Tannock
Journal:  Support Care Cancer       Date:  2010-03-30       Impact factor: 3.603

7.  Trait anxiety as an independent predictor of poor health-related quality of life and post-traumatic stress symptoms in rectal cancer.

Authors:  Stephen L Ristvedt; Kathryn M Trinkaus
Journal:  Br J Health Psychol       Date:  2009-01-24

8.  What Factors are Associated With Quality Of Life, Pain Interference, Anxiety, and Depression in Patients With Metastatic Bone Disease?

Authors:  Q M J van der Vliet; N R Paulino Pereira; S J Janssen; F J Hornicek; M L Ferrone; J A M Bramer; C N van Dijk; J H Schwab
Journal:  Clin Orthop Relat Res       Date:  2016-10-17       Impact factor: 4.176

9.  Predicting distress among people who care for patients living longer with high-grade malignant glioma.

Authors:  B Russell; A Collins; A Dowling; M Dally; M Gold; M Murphy; J Burchell; J Philip
Journal:  Support Care Cancer       Date:  2015-04-25       Impact factor: 3.603

10.  Does quality of life among breast cancer survivors one year after diagnosis differ depending on urban and non-urban residence? A comparative study.

Authors:  Tracey DiSipio; Sandi C Hayes; Beth Newman; Joanne Aitken; Monika Janda
Journal:  Health Qual Life Outcomes       Date:  2010-01-07       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.